I-Cod Liver Oil

-Delile

• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

Amafutha wesibindi se-cod angatholakala ngokudla isibindi esisha se-cod noma ngokuthatha izithako.

Uwoyela wesibindi seCod usetshenziswa njengomthombo kavithamini A novithamini D. Iphinde isetshenziswe njengomthombo wamafutha abizwa nge-omega-3 wezempilo yenhliziyo, ukudangala, isifo samathambo, nezinye izimo, kepha abukho ubufakazi obuhle besayensi bokusebenzisa .

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze I-COD LIVER OIL zimi kanje:

Ubufakazi obanele bokukala ukusebenza kwe ...

• Isifo samehlo esiholela ekulahlekelweni kombono kubantu abadala (ukuwohloka okuhlobene nobudala noma i-AMD). Abantu abadla izinhlanzi eziningi futhi bathathe uwoyela wesibindi se-cod abanabo ubungozi obuphansi bokuba nalesi simo uma kuqhathaniswa nabantu abadla izinhlanzi eziningi nje.
• Imfiva ethimulisayo. Ukuthatha uwoyela wesibindi se-cod ngesikhathi sokukhulelwa noma ngenkathi uncelisa, noma ukunikeza uwoyela wesibindi se-cod enganeni kuze kufike eminyakeni emibili ubudala, kubonakala kungavimbeli i-hay fever.
• Ukushaya kwenhliziyo okungajwayelekile (arrhythmia). Ukuthatha uwoyela we-cod ngomlomo kunganciphisa uhlobo oluthile lokushaya kwenhliziyo okungajwayelekile kwabanye abantu. Kodwa akwaziwa ukuthi lokhu kunciphisa ingozi yokufa okuhlobene nenhliziyo. Ukuthatha uwoyela we-cod ngomlomo akubonakali kunciphisa ukushaya kwenhliziyo okungajwayelekile emadodeni anokushaya kwenhliziyo okungajwayelekile ngemuva kokuhlaselwa yinhliziyo.
• Isifuba Somoya. Ucwaningo oluningi lukhombisa ukuthi ukuthatha uwoyela wesibindi se-cod ngesikhathi sokukhulelwa noma ukuncelisa ibele, noma ukunika uwoyela we-cod isibindi enganeni efika eminyakeni emibili ubudala, akuvimbeli i-asthma. Kepha ukuthatha uwoyela we-cod isibindi izikhathi eziyi-1-3 masonto onke ngesikhathi sokukhulelwa kunganciphisa ubungozi be-asthma enganeni ineminyaka engu-6 ubudala.
• I-eczema (i-atopic dermatitis). Ucwaningo oluningi lukhombisa ukuthi ukuthatha uwoyela wesibindi se-cod ngesikhathi sokukhulelwa noma ukuncelisa ibele, noma ukunika uwoyela we-cod isibindi enganeni efika eminyakeni emibili ubudala, akuvimbeli i-eczema. Kepha zimbalwa izinsana ezine-eczema ezinonyaka owodwa ubudala uma zithatha uwoyela we-cod okungenani izikhathi ezine ngesonto.
• Ukucindezeleka. Ukuthatha uwoyela we-cod wesibindi kuxhunyaniswe namathuba aphansi angama-29% abantu abadala asebekhulile abanezimpawu zokucindezeleka.
• Isifo sikashukela. Ukuthatha uwoyela we-cod kungasiza ekulawuleni ushukela wegazi kubantu abanesifo sikashukela ngesikhathi sokukhulelwa. Lokhu kungasiza ukuvimbela izinkinga lapho uzalwa. Kungathatha kuze kube amasonto ayi-12 ukuze uzuze. Ukuthatha uwoyela wesibindi i-cod akubonakali kusiza ekulawuleni ushukela egazini kubantu abanesifo sikashukela sohlobo 1.
• Ukuthambekela okuzuzwe njengefa kwe-cholesterol ephezulu (i-hypercholesterolemia yomndeni). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha uwoyela wesibindi se-cod akubonakali kwehlisa amazinga e-cholesterol kubantu abane-hypercholesterolemia yomndeni.
• I-cholesterol ephezulu. Ukuthatha uwoyela we-cod ngomlomo akwehlisi amazinga e-cholesterol kubantu abane-cholesterol ephezulu. Kepha kungakhuphula amazinga "aphezulu" we-high-density lipoprotein cholesterol kubantu abanesifo sikashukela sohlobo 1 kanye ne-cholesterol ephezulu. Futhi kungehlisa amafutha egazi abizwa nge- "triglycerides" emadodeni ahlaselwe yisifo senhliziyo.
• Umfutho wegazi ophezulu. Ukuthatha uwoyela we-cod ngesibindi ngomlomo kubonakala kwehlisa umfutho wegazi kubantu abaphilile nalabo abanengcindezi ephezulu yegazi. Kodwa akucaci ukuthi lokhu kuncishiswa kunenjongo yokwelashwa kubantu abane-cholesterol ephezulu kakhulu.
• Ukuvuvukala kwesikhathi eside (ukuvuvukala) emkhakheni wokugaya ukudla (isifo sokuvuvukala kwamathumbu noma i-IBD). Abanye abantu abanezifo zamathumbu ezivuthayo banezinhlungu ezihlangene. Ukuthatha uwoyela we-cod kunganciphisa ubuhlungu obuhlangene kwabanye abantu abanalesi simo.
• I-osteoarthritis. Ukuthatha uwoyela wesibindi se-cod kanye ne-NSAID akukwehlisi ukuvuvukala kubantu abane-osteoarthritis kangcono kunokuthatha i-NSAID yodwa.
• Ukutheleleka kwendlebe (i-otitis media). Ukuthatha uwoyela we-cod kanye ne-multivitamin kunganciphisa isidingo sokusebenzisa umuthi ukwelapha ukutheleleka kwezindlebe ezinganeni ezisencane cishe nge-12%.
• Ukutheleleka kwemigwaqo yomoya. Ukunikeza izingane ezincane uwoyela wesibindi se-cod kanye ne-multivitamin kubonakala kunciphisa inani lokuvakasha kwamahhovisi kadokotela kwizifo ezihamba emoyeni.
• Isifo samathambo (RA). Ukuthatha uwoyela wesibindi kunganciphisa ubuhlungu, ukuqina kwasekuseni nokuvuvukala kwezinye iziguli ezine-arthritis ye-rheumatoid. Futhi, ukuthatha uwoyela we-cod ne-oyili yezinhlanzi kubonakala kunciphisa isidingo sokusebenzisa umuthi ukwelapha ukuvuvukala okuhlangene kubantu abanalesi simo.
• Ukushoda kukavithamini D. Ukuthatha uwoyela wesibindi se-cod kubonakala kukhuphula amazinga egazi likavithamini D kwabanye abantu. Kodwa akucaci ukuthi uwoyela wesibindi se-cod unyusa uvithamini D uye emazingeni ajwayelekile kubantu abanamazinga aphansi kavithamini D.
• Iqembu lokuphazamiseka kwamehlo okungaholela ekulahlekelweni kombono (glaucoma).
• Ukusabela kwesikhumba okweqile.
• Kushe.
• Ukuqubuka kwe-diaper.
• Isifo senhliziyo.
• Ama-hemorrhoids.
• Amazinga aphezulu amafutha abizwa nge-triglycerides egazini (hypertriglyceridemia).
• Ukulimala kwezinso kubantu abanesifo sikashukela (isifo sikashukela nephropathy). .
• Ukuphulukiswa kwesilonda.
• Ezinye izimo.

Kudingeka ubufakazi obengeziwe ukukala uwoyela we-cod wesibindi ngalokhu kusetshenziswa.

Uwoyela wesibindi seCod uqukethe "ama-fatty acids" athile avimbela igazi ekunqandeni kalula. Lawa mafutha acid abuye anciphise ubuhlungu nokuvuvukala.

Lapho ithathwa ngomlomo: Uwoyela wesibindi we-cod uyi CISHE UVIKILE kubantu abaningi abadala lapho bethathwa ngomlomo. Kungadala imiphumela engemihle kufaka phakathi ukubopha, ukuphefumula kabi, isilungulela, indle evulekile, nesicanucanu. Ukuthatha uwoyela we-cod wesibindi ngokudla kunganciphisa le miphumela emibi. Imithamo ephezulu kawoyela we-cod isibindi kukhona MHLAWUMBI ANGIPHEPHILE. Zingavimbela igazi ekunqandeni futhi zingakhuphula amathuba okuphuma kwegazi. Amavithamini A novithamini D amazinga nawo angaphakama kakhulu ngamanani aphezulu kawoyela we-cod wesibindi.

Lapho isetshenziswa esikhunjeni: Alukho ulwazi olwanele oluthembekile lokwazi ukuthi ngabe uwoyela wesibindi se-cod uphephile yini noma yini imiphumela emibi engaba khona.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Uwoyela wesibindi we-cod uyi OKUNGENZEKA UKUPHEPHA lapho isetshenziswa ngamanani angahlinzeki ngaphezu kokunconywayo nsuku zonke kukavithamini A novithamini D. Cod oil oil is MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngamanani amakhulu. Abesifazane abakhulelwe noma abancelisayo akufanele bathathe uwoyela we-cod wesibindi ohlinzeka ngaphezu kuka-3000 mcg kavithamini A no-100 mcg kavithamini D.

Izingane: Uwoyela wesibindi we-cod uyi CISHE UVIKILE ezinganeni eziningi lapho zithathwa ngomlomo ngamanani angahlinzeki ngaphezu kokunconywayo nsuku zonke kukavithamini A novithamini D. Amafutha wesibindi i-Cod MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngamanani amakhulu.

Isifo sikashukela: Kube nokukhathazeka okuthile ngokuthi uwoyela wesibindi se-cod noma amanye amafutha wezinhlanzi angakhuphula ushukela wegazi kubantu abanesifo sikashukela. Kepha alukho ucwaningo oluqinile olusekela lokhu kukhathazeka. Kepha kunobunye ubufakazi bokuthi uwoyela we-cod wesibindi ungehlisa amazinga kashukela egazini futhi wandise imiphumela yokwehlisa ushukela egazini yeminye imishanguzo yokulwa nesifo sikashukela. Kukhona ukukhathazeka ukuthi ushukela wegazi ungehla kakhulu. Uma unesifo sikashukela futhi usebenzisa uwoyela we-cod, qapha amazinga kashukela egazini lakho.

Maphakathi

Qaphela ngale nhlanganisela.

Imithi yesifo sikashukela (Imithi elwa nesifo sikashukela)

Uwoyela wesibindi weCod ungehlisa amazinga kashukela egazini. Imithi yesifo sikashukela isetshenziselwa ukwehlisa ushukela wegazi. Ukuthatha uwoyela we-cod kanye nemithi yesifo sikashukela kungadala ukuthi ushukela wegazi lakho wehle kakhulu. Bheka ushukela wegazi lakho eduze. Umthamo wemithi yakho yesifo sikashukela ungadinga ukuguqulwa.
Eminye imishanguzo esetshenziselwa isifo sikashukela ifaka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-metformin (i-Glucophage), i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbotide Orinase), nabanye.

Imithi yokwelapha umfutho wegazi ophakeme (Imithi efuthayo)

Uwoyela wesibindi seCod ubukeka wehla umfutho wegazi. Ukuthatha uwoyela we-cod kanye nemithi yomfutho wegazi ophezulu kungadala ukuthi umfutho wegazi lakho wehle kakhulu.

Eminye imishanguzo yomfutho wegazi ophakeme ihlanganisa i-captopril (Capoten), i-enalapril (i-Vasotec), i-losartan (i-Cozaar), i-valsartan (i-Diovan), i-diltiazem (i-Cardizem), i-amlodipine (i-Norvasc), i-hydrochlorothiazide (i-HydroDIURIL), i-furosemide (i-Lasix), neminye eminingi .

Imithi eyehlisa ukunqamuka kwegazi (Anticoagulant / Antiplatelet drug)

Uwoyela wesibindi we-cod unganciphisa ukuvimba kwegazi. Ukuthatha uwoyela we-cod kanye nemithi epholisa nokuqina kungakhuphula amathuba okulimala nokopha.

Eminye imithi eyehlisa ijubane ukuvala igazi ifaka phakathi i-aspirin, i-clopidogrel (i-Plavix), i-diclofenac (i-Voltaren, i-Cataflam, abanye), i-dipyridamole (i-Persantine), i-ibuprofen (i-Advil, i-Motrin, abanye), i-naproxen (i-Anaprox, i-Naprosyn, enye), i-dalteparin (i-Fragmin) , enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), warfarin (Coumadin), nabanye.

Amakhambi nezengezo ezinganciphisa umfutho wegazi

Uwoyela wesibindi weCod ungehlisa umfutho wegazi. Inamandla okwengeza kumfutho wegazi wehlisa imiphumela yamanye amakhambi nezengezo eziphinde zehlise umfutho wegazi. Amanye amakhambi nezithasiselo ezinganciphisa umfutho wegazi zifaka i-andrographis, i-casein peptides, uzipho lwekati, i-coenzyme Q10, i-L-arginine, i-lycium, i-nettle ehlabayo, i-theanine, nezinye.

Amakhambi nezithasiselo ezingehlisa ushukela egazini

Uwoyela wesibindi we-cod unganciphisa ushukela wegazi. Uma ithathwa kanye namanye amakhambi nezengezo ezinganciphisa ushukela wegazi, ushukela wegazi ungancipha kakhulu kwabanye abantu. Amanye amakhambi nezithasiselo ezinganciphisa ushukela wegazi zifaka i-alpha-lipoic acid, ikhabe elibabayo, i-chromium, uzipho lukaSathane, i-fenugreek, i-garlic, i-guar gum, i-chestnut yamahhashi, i-Panax ginseng, i-psyllium, i-ginseng yaseSiberia, nokunye.

Amakhambi nezengezo ezinganciphisa ukujiya kwegazi

Uwoyela wesibindi we-cod unganciphisa ukuvimba kwegazi. Ukusebenzisa uwoyela we-cod wesibindi ngamakhambi kanye nezithasiselo futhi ezihamba kancane ekunqandeni kwegazi kungakhuphula ithuba lokulimala nokopha kwabanye abantu. Lawa makhambi afaka i-angelica, uwoyela wembewu ye-borage, i-clove, i-danshen, i-garlic, i-ginger, i-ginkgo, i-red clover, i-turmeric, i-willow, nezinye.

Akukho ukuxhumana okwaziwayo nokudla.

Umthamo ofanele kawoyela we-cod wesibindi uncike ezintweni eziningana ezifana nobudala bomsebenzisi, impilo, nezinye izimo eziningana. Ngalesi sikhathi alukho ulwazi olwanele lwesayensi lokunquma uhla olufanele lwemithamo yamafutha we-cod cod. Khumbula ukuthi imikhiqizo yemvelo ayihlali iphephile njalo futhi imithamo ingabaluleka. Qiniseka ukuthi ulandela izinkomba ezifanele kumalebula womkhiqizo futhi uthintane nosokhemisi wakho noma udokotela noma omunye uchwepheshe wezokunakekelwa kwempilo ngaphambi kokusebenzisa. Aceite de Higado de Bacalao, Acides Gras Oméga 3, Acides Gras N-3, Acides Gras Polyinsaturés, Cod Oil, Fish Liver Oil, Fish Oil, Halibut Liver Oil, Huile de Foie, Huile de Foie de Flétan, Huile de Foie de Morue , Huile de Foie de Poisson, Huile de Moriss, Huile de Poisson, Liver Oil, N-3 Fatty Acids, Omega 3, Oméga 3, Omega 3 Fatty Acids, Omega-3, Omega-3 Fatty Acids, Polyunsaturated Fatty Acids.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. UConus N, uBurgher-Kennedy N, van den Berg F, uKaur Datta G. Isivivinyo esingahleliwe siqhathanisa amazinga e-omega-3 fatty acid plasma ngemuva kokungeniswa kwamafutha we-cod wesibindi e-emulsified and non-emulsified. I-Curr Med Res Opin. 2019; 35: 587-593. Buka okungaqondakali.
2. U-enien T, uSchjelvaag A, uStorrsen O, uJohnsen R, uSimpson MR. Ukusetshenziswa kwezinhlanzi unyaka owodwa ubudala kunciphisa ubungozi be-eczema, i-asthma kanye ne-wheeze lapho ineminyaka eyisithupha ubudala. Izakhamzimba. 2019; 11. pii: E1969. Buka okungaqondakali.
3. UYang S, Lin R, Si L, et al. Uwoyela we-cod-isibindi uthuthukisa ama-indices we-metabolic namazinga e-hs-CRP ezigulini zesifo sikashukela sokukhulelwa: Isilingo esilawulwa kabili esingahleliwe esilawulwa ngokungahleliwe. J Isifo Sikashukela Res. 2019; 2019: 7074042. Buka okungaqondakali.
4. UHelland IB, uSaarem K, uSaugstad OD, uDrevon CA. Ukwakheka kwamafutha e-asidi obisini lomama kanye ne-plasma ngesikhathi sokungezelelwa ngamafutha we-cod wesibindi. I-Eur J Clin Nutr 1998; 52: 839-45. Buka okungaqondakali.
5. UBartolucci G, uGiocaliere E, uBoscaro F, et al. Ukulinganiswa kukavithamini D3 kusengezo esisekelwa uwoyela we-cod. UJ Pharm Biomed Anal 2011; 55: 64-70. Buka okungaqondakali.
6. ILinday LA. Uwoyela wesibindi we-cod, izingane ezincane, kanye nezifo ezingaphezulu zokuphefumula. J Ngingu-Nut Nutrit 2010; 29: 559-62. Buka okungaqondakali.
7. U-Olafsdottir AS, uThorsdottir I, uWagner KH, u-Elmadfa I. I-Polyunsaturated fatty acids ekudleni nobisi lwebele lwabesifazane abancelisayo base-Iceland abanezinhlanzi zendabuko kanye nokusetshenziswa kwamafutha e-cod. U-Ann Nutr Metab 2006; 50: 270-6. Buka okungaqondakali.
8. UHelland IB, uSaugstad OD, uSaarem K, et al. Ukwengezwa kwama-n-3 fatty acids ngesikhathi sokukhulelwa kanye nokuncelisa kunciphisa amazinga e-plasma lipid womama futhi kunikeza i-DHA ezinganeni. J Matern Fetal Neonatal Med 2006; 19: 397-406. Buka okungaqondakali.
9. UFoti C, uBonamonte D, i-Conserva A, uPepe ML, u-Angelini G. Allergic contact dermatitis kumafutha wesibindi we-cod aqukethe okokugcoba kwesihloko. Xhumana noDermatitis 2007; 57: 281-2. Buka okungaqondakali.
10. UMavroeidi A, Aucott L, uBlack AJ, et al. Ukwehluka kwesizini ku-25 (OH) D e-Aberdeen (57 ° N) kanye nezinkomba zempilo yethambo - kungabe amaholidi elangeni kanye namafutha we-cod wesibindi anciphisa ukushoda? Ama-PLoS One 2013; 8: e53381. Buka okungaqondakali.
11. I-Eysteinsdottir T, iHalldorsson TI, iThorsdottir I, et al. Ukusetshenziswa kukawoyela we-Cod ngezikhathi ezahlukahlukene zokuphila nobuningi bamathambo lapho usumdala. UBr J Nutriti 2015; 114: 248-56. Buka okungaqondakali.
12. UHardarson T, uKristinsson A, uSkúladóttir G, u-Asvaldsdóttir H, uSnorrason SP. Uwoyela wesibindi we-cod awunciphisi ama-ventricular extrasystoles ngemuva kwe-infarction ye-myocardial. J Intern Med 1989; 226: 33-7. Buka okungaqondakali.
13. ISkúladóttir GV, uGudmundsdóttir E, u-Olafsdóttir E, et al. Ithonya lamafutha we-cod wesibindi ekudleni okunamafutha acid ukwakheka kwe-plasma lipids ezifundweni zesilisa zomuntu ngemuva kwe-infarction ye-myocardial. J Intern Med 1990; 228: 563-8. Buka okungaqondakali.
14. UGruenwald J, Graubaum HJ, Harde A. Umphumela wamafutha we-cod wesibindi kuzimpawu zesifo samathambo. U-Adv Ther 2002; 19: 101-7. Buka okungaqondakali.
15. ILinday LA, iShindledecker RD, iTapia-Mendoza J, iDolitsky JN. Umphumela kawoyela we-cod wesibindi nsuku zonke kanye ne-multivitamin-multimineral supplement ne-selenium ekuvakasheni okuphezulu kwezingane okuphefumula okuvakashelwa yizingane ezisencane, zangaphakathi kwedolobha, zaseLatino: amasayithi ezingane angahleliwe. U-Ann Otol Rhinol Laryngol 2004; 113: 891-901. Buka okungaqondakali.
16. I-Porojnicu AC, i-Bruland OS, i-Aksnes L, i-Brant WB, i-Moan J. Imibhede yelanga kanye namafutha we-cod wesibindi njengemithombo kavithamini D. J Photochem Photobiol B Biol 2008; 91: 125-31. Buka okungaqondakali.
17. IBrunborg LA, iMadland TM, iLind RA, et al. Imiphumela yokuphathwa komlomo okwesikhashana kwamafutha asolwandle okudliwayo ezigulini ezinesifo samathumbu esivuthayo nobuhlungu obuhlangene: isifundo somshayeli siqhathanisa uwoyela we-seal kanye ne-cod liver oil. I-Clin Nutr 2008; 27: 614-22. Buka okungaqondakali.
18. UJonasson F, Fisher DE, u-Eiriksdottir G, et al. Izigameko zeminyaka emihlanu, ukuqhubeka, kanye nezici zobungozi bokuwohloka kwe-macular okuhlobene nobudala: ubudala, ucwaningo lokuthambekela kofuzo / kwemvelo. I-Ophthalmology 2014; 121: 1766-72. Buka okungaqondakali.
19. I-Mai XM, iLanghammer A, Chen Y, iCamargo CA. Ukudla kukawoyela we-Cod kanye nesifo se-asthma kubantu abadala baseNorway - isifundo se-HUNT. Isikhulu 2013; 68: 25-30. Buka okungaqondakali.
20. UDopopoulou P, uPapamikos V. Ukopha emathunjini ngemuva kokudla okuphezulu kwama-omega-3 fatty acids, i-cortisone kanye ne-antibiotic therapy: isifundo secala. I-Int J Sport Nutr Exerc Metab 2014; 24: 253-7. Buka okungaqondakali.
21. URoss AC, Taylor CL, Yaktine AL, Del Valle HB (ama-eds). Ukufakwa kwezithenjwa zokudla nge-calcium novithamini D. Isikhungo Sezokwelapha, 2011. Kutholakala ku: www.nap.edu/catalog/13050/dietary-reference-intakes-for-calcium-and-vitamin-d (kufinyelelwe ngo-Ephreli 17, 2016) .
22. U-Ahmed AA, uHolub BJ. Ukuguqulwa nokubuyiselwa kwezikhathi zokopha, ukuhlanganiswa kweplatelet kanye nokwakheka kwamafutha acid we-phospholipids ngayinye kuma-platelet ezihloko zabantu ezithola isithasiselo samafutha we-cod-liver. I-Lipids 1984; 19: 617-24. Buka okungaqondakali.
23. Lorenz R, Spengler U, Fischer S, Duhm J, Weber PC.Umsebenzi wePlatelet, ukwakheka kwe-thromboxane nokulawulwa kwengcindezi yegazi ngesikhathi sokungezelelwa kokudla kwaseNtshonalanga ngamafutha we-cod wesibindi. Ukusakazwa kuka-1983; 67: 504-11. Buka okungaqondakali.
24. UGalarraga, B., Ho, M., Youssef, HM, Hill, A., McMahon, H., Hall, C., Ogston, S., Nuki, G., noBelch, uwoyela wesibindi we-JJ Cod (n-3 fatty acids) njenge-agent engeyona i-steroidal anti-inflammatory drug sparing agent ku-rheumatoid arthritis. I-Rheumatology. (Oxford) 2008; 47: 665-669. Buka okungaqondakali.
25. URaeder MB, uSteen VM, uVollset SE, uBjelland I. Izinhlangano phakathi kokusetshenziswa kukawoyela we-cod nezimpawu zokucindezeleka: IHordaland Health Study. J Kuthinta Ukungezwani 2007; 101: 245-9. Buka okungaqondakali.
26. UMlimi A, uMontori V, uDinneen S, uClar C. Amafutha ezinhlanzi kubantu abane-type 2 yesifo sikashukela. ICochrane Database Syst Rev 2001; 3: CD003205. Buka okungaqondakali.
27. ILinday LA, iDolitsky JN, iShindledecker RD, iPippenger CE. Amafutha we-cod-flavored cod wesibindi kanye ne-multivitamin-mineral supplement yokuvikela okwesibili i-otitis media ezinganeni ezincane: ucwaningo lomshayeli. U-Ann Otol Rhinol Laryngol 2002: 111: 642-52 .. Buka okungaqondakali.
28. UBrox JH, uKillie JE, u-Osterud B, et al. Imiphumela kawoyela wesibindi se-cod kuma-platelet nokuqina kwe-hypercholesterolemia yomndeni (uhlobo IIa). I-Acta Med Scand 1983; 213: 137-44 .. Buka okungaqondakali.
29. ILandymore RW, iMacAulay MA, iCooper JH, iSheridan BL. Imiphumela kawoyela we-cod-isibindi ku-hyperplasia enhle emithanjeni ye-vein esetshenziselwa ukudlula kwe-arterial. Can J Surg 1986; 29: 129-31 .. Buka okungaqondakali.
30. i-al-Meshal MA, i-Lutfi KM, i-Tariq M. Cod kawoyela wesibindi ivimbela i-indomethacin eyenze isisu ngaphandle kokuthinta ukutholakala kwayo nokusebenza kwemithi. ILife Sci 1991; 48: 1401-9 .. Buka okungaqondakali.
31. UHansen JB, u-Olsen JO, uWilsgard L, u-Osterud B. Imiphumela yokwengeza kokudla ngamafutha we-cod wesibindi ku-monocyte thromboplastin synthesis, coagulation kanye ne-fibrinolysis. J Intern Med Suppl 1989; 225: 133-9 .. Buka okungaqondakali.
32. I-Aviram M, i-Brox J, i-Nordoy A. Imiphumela ye-postprandial plasma nama-chylomicrons kumaseli we-endothelial. Umehluko phakathi kokhilimu wokudla ne-cod oyili yesibindi. I-Acta Med Scand 1986; 219: 341-8 .. Buka okungaqondakali.
33. USellmayer A, Witzgall H, Lorenz RL, Weber PC. Imiphumela yokudla kukawoyela wezinhlanzi ezakhiweni ezingaphambi kwesikhathi ze-ventricular. NginguJ J Cardiol 1995; 76: 974-7. Buka okungaqondakali.
34. IBhodi Yezokudla Nezokudla, Isikhungo Sezokwelapha. Ukufakwa Kwezikhombo Zezokudla ku-Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, neZinc. Washington, DC: National Academy Press, 2002. Itholakala ku: www.nap.edu/books/0309072794/html/.
35. USanders TA, uVickers M, uHaines AP. Umphumela kuma-lipids egazi kanye ne-haemostasis yesengezo samafutha we-cod-isibindi, acebile ngama-eicosapentainoic kanye ne-docosahexaenoic acid, ezinsizweni ezinempilo. I-Clin Sci (Colch) 1981; 61: 317-24. Buka okungaqondakali.
36. I-Brox JH, i-Killie JE, i-Gunnes S, i-Nordoy A. Umphumela wamafutha we-cod namafutha ommbila kuma-platelets nasodongeni lomkhumbi kumuntu. UTromb Haemost 1981; 46: 604-11. Buka okungaqondakali.
37. ILandymore RW, iKinley CE, uCooper JH, et al. Uwoyela we-cod-isibindi ekuvikeleni i-hyperplasia enhle emithanjeni yemithambo ezenzakalelayo esetshenziselwa ukudlula kwemithambo. UJ Thorac Cardiovasc Ukuhlinzwa 1985; 89: 351-7. Buka okungaqondakali.
38. I-Landymore RW, iMacAulay M, uSheridan B, uCameron C. Ukuqhathaniswa kwamafutha we-cod-isibindi kanye ne-aspirin-dipyridamole yokuvimbela i-hyperplasia enhle emithanjeni ye-veologous vein. U-Ann Thorac Surg 1986; 41: 54-7. Buka okungaqondakali.
39. UHenderson MJ, uJones RG. Amafutha wesibindi se-cod noma i-bust. ILancet 1987; 2: 274-5.
40. Anon. Ukugxila kukawoyela wezinhlanzi onamalayisense uma kuqhathaniswa namafutha we-cod-liver. ILancet 1987; 2: 453.
41. UJensen T, uStender S, uGoldstein K, et al. Ukujwayela okuyingxenye ngoyili wokudla we-cod-isibindi wokukhuphuka kokuvuza kwe-albhamuvas ezigulini ezinesifo sikashukela esincike ku-insulin kanye ne-albinuria. N Engl J Med 1989; 321: 1572-7. Buka okungaqondakali.
42. I-Stammers T, i-Sibbald B, i-Freeling P. Ukusebenza kahle kukawoyela we-cod wesibindi njengokuhambisana nokwelashwa kwezidakamizwa ezingezona ukuvuvukala ekuphatheni i-osteoarthritis ngokujwayelekile. U-Ann Rheum Dis 1992; 51: 128-9. Buka okungaqondakali.
43. ULombardo YB, uChicco A, uD'Alessandro ME, et al. Amafutha wezinhlanzi ezidliwayo enza ukubekezelela i-dyslipidemia ne-glucose ukungabekezelelani ngamazinga e-insulin angashintshi kumagundane ondle ukudla okuphezulu kwe-sucrose. I-Biochim Biophys Acta 1996; 1299: 175-82. Buka okungaqondakali.
44. UDawson JK, u-Abernethy VE, uGraham DR, iLungu lePhalamende laseLynch. Owesifazane othathe uwoyela wesibindi se-cod wabhema. ILancet 1996; 347: 1804.
45. I-Veierod MB, i-Thelle DS, i-Laake P. Ukudla kanye nobungozi be-melanoma enobungozi obunqamulelayo: isifundo esizayo sabesilisa nabesifazane baseNorway abangama-50,757. I-Int J Cancer 1997; 71: 600-4. Buka okungaqondakali.
46. UTerkelsen LH, u-Eskild-Jensen A, uKjeldsen H, et al. Ukusetshenziswa kwesihloko kwamafutha kawoyela we-cod kusheshisa ukuphulukiswa kwesilonda: isifundo sokuhlola emanxebeni asezindlebeni zamagundane angenazinwele. IScand J Plast Reconstr Surg Hand Surg 2000; 34: 15-20. Buka okungaqondakali.
47. I-FDA. Isikhungo Sokuphepha Kokudla Nokudla Okusetshenzisiwe. Incwadi ephathelene nesimangalo sezempilo sokungezelela ekudleni kwe-omega-3 fatty acids nesifo senhliziyo. Kutholakala ku: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-Rpt0272-38-Appendix-D-Reference-F-FDA-vol205.pdf. (Kufinyelelwe ngoFebhuwari 7, 2017).
48. UShimizu H, Ohtani K, Tanaka Y, et al. Umphumela wesikhathi eside we-eicosapentaenoic acid ethyl (EPA-E) ku-albuminuria yeziguli ezinesifo sikashukela ezincike ku-insulin. Isifo Sikashukela Res Clin Pract 1995; 28: 35-40. Buka okungaqondakali.
49. UToft I, Bonaa KH, Ingebretsen OC, et al. Imiphumela yama-n-3 polyunsaturated fatty acids ku-glucose homeostasis nomfutho wegazi ku-hypertension ebalulekile. Isivivinyo esingahleliwe, esilawulwayo. U-Ann Intern Med 1995; 123: 911-8. Buka okungaqondakali.
50. UPrisco D, uPaniccia R, uBandinelli B, et al. Umphumela wokwengezelelwa kwesikhathi esimaphakathi ngomthamo olinganiselayo wama-n-3 polyunsaturated fatty acids ekucindezelekeni kwegazi ezigulini ezinomfutho ophakeme wegazi. IThromb Res 1998; 1: 105-12. Buka okungaqondakali.
51. IGibson RA. Ama-acids ama-polyunsaturated amakhemikhali amade kanye nokuthuthukiswa kwezinsana (kokuhlela). ILancet 1999; 354: 1919.
52. ULucas A, uStafford M, uMorley R, et al. Ukusebenza nokuphepha kwe-chain chain ende ye-polyunsaturated fatty supplementation yobisi lwefomula yezingane: isilingo esingahleliwe. ILancet 1999; 354: 1948-54. Buka okungaqondakali.

Kugcine ukubuyekezwa - 02/12/2021